CUSPIDI, CESARE
 Distribuzione geografica
Continente #
NA - Nord America 53.872
AS - Asia 26.951
EU - Europa 17.540
SA - Sud America 3.797
AF - Africa 548
OC - Oceania 61
Continente sconosciuto - Info sul continente non disponibili 21
Totale 102.790
Nazione #
US - Stati Uniti d'America 50.091
SG - Singapore 9.753
CN - Cina 4.870
HK - Hong Kong 4.706
IT - Italia 4.567
VN - Vietnam 3.799
RU - Federazione Russa 3.476
CA - Canada 3.410
BR - Brasile 2.917
IE - Irlanda 1.993
UA - Ucraina 1.616
SE - Svezia 1.574
DE - Germania 1.224
BD - Bangladesh 931
GB - Regno Unito 893
FR - Francia 873
IN - India 583
FI - Finlandia 484
AR - Argentina 346
TR - Turchia 323
IQ - Iraq 285
ID - Indonesia 284
KR - Corea 280
MX - Messico 189
PK - Pakistan 172
ZA - Sudafrica 159
EC - Ecuador 157
NL - Olanda 135
JP - Giappone 131
SA - Arabia Saudita 129
AT - Austria 109
CO - Colombia 109
PH - Filippine 108
UZ - Uzbekistan 104
ES - Italia 97
PL - Polonia 95
VE - Venezuela 81
DK - Danimarca 79
MY - Malesia 68
MA - Marocco 65
CL - Cile 64
EG - Egitto 56
KE - Kenya 55
TN - Tunisia 50
PY - Paraguay 48
AU - Australia 47
TH - Thailandia 43
BE - Belgio 42
CZ - Repubblica Ceca 42
JM - Giamaica 39
ET - Etiopia 38
NP - Nepal 38
AE - Emirati Arabi Uniti 36
CR - Costa Rica 32
DZ - Algeria 31
JO - Giordania 29
PE - Perù 28
RO - Romania 27
AZ - Azerbaigian 26
OM - Oman 26
KZ - Kazakistan 25
IR - Iran 23
TT - Trinidad e Tobago 23
PS - Palestinian Territory 22
UY - Uruguay 22
IL - Israele 21
LT - Lituania 21
NG - Nigeria 21
BG - Bulgaria 20
BO - Bolivia 20
HN - Honduras 20
TW - Taiwan 20
GR - Grecia 19
AL - Albania 17
DO - Repubblica Dominicana 16
GT - Guatemala 16
KG - Kirghizistan 16
LB - Libano 16
RS - Serbia 16
PT - Portogallo 15
SN - Senegal 15
HU - Ungheria 14
CH - Svizzera 13
GE - Georgia 13
NZ - Nuova Zelanda 13
BA - Bosnia-Erzegovina 11
EU - Europa 11
SY - Repubblica araba siriana 11
BH - Bahrain 10
BY - Bielorussia 10
LK - Sri Lanka 10
QA - Qatar 10
SK - Slovacchia (Repubblica Slovacca) 10
EE - Estonia 9
MD - Moldavia 9
NO - Norvegia 9
PA - Panama 9
NI - Nicaragua 8
AM - Armenia 7
MU - Mauritius 7
Totale 102.660
Città #
Ann Arbor 7.848
Singapore 5.119
Hong Kong 4.655
Woodbridge 4.360
Fairfield 4.240
Ashburn 3.630
Houston 3.122
Toronto 2.822
San Jose 1.960
Dublin 1.874
Jacksonville 1.825
Wilmington 1.825
Milan 1.691
Seattle 1.642
Cambridge 1.399
Dearborn 1.364
Chandler 1.363
New York 1.203
Ho Chi Minh City 1.130
Princeton 1.003
Chicago 910
Hanoi 873
The Dalles 775
Dallas 727
Santa Clara 691
Frankfurt am Main 655
Beijing 654
Los Angeles 551
Hefei 534
Lauterbourg 497
Lawrence 479
Altamura 453
Rome 427
Nanjing 423
Moscow 328
Lachine 310
San Diego 310
São Paulo 267
Seoul 255
Council Bluffs 249
Buffalo 215
Boardman 191
Dong Ket 171
Shanghai 165
Guangzhou 155
Jakarta 153
Nanchang 146
Shenyang 145
Andover 139
Salt Lake City 139
Da Nang 138
Haiphong 129
Hebei 120
London 119
Baghdad 116
Helsinki 110
Orem 105
Munich 95
Falls Church 94
Tianjin 94
Ottawa 92
Rio de Janeiro 92
Changsha 89
Tokyo 89
Norwalk 88
Turin 88
Tashkent 85
Figino 83
Jiaxing 81
Phoenix 73
Tampa 73
Columbus 72
Nuremberg 71
Detroit 69
Atlanta 67
Jinan 66
Quito 66
Hangzhou 65
Chennai 62
Dhaka 62
Johannesburg 62
Naples 62
Warsaw 62
Brooklyn 61
Vienna 61
Can Tho 58
Montreal 58
Biên Hòa 57
Brasília 55
San Francisco 55
Washington 55
Zhengzhou 55
Denver 53
Hải Dương 53
Lahore 53
Quận Bình Thạnh 52
Nairobi 49
Mexico City 48
Belo Horizonte 47
Kunming 46
Totale 69.817
Nome #
Echocardiographic Phenotypes of Subclinical Organ Damage: Clinical and Prognostic Value in the General Population. Findings from the Pamela Study 601
Myocardial Mechanics in Acromegaly: A Meta-Analysis of Echocardiographic Studies 479
Sympathetic Overactivation in the Resistant Hypertensive Phenotype: A Meta-Analysis of Published Studies 426
Reproducibility of dipping/nondipping pattern in untreated essential hypertensive patients: impact of sex and age 382
Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program 379
Cardiopulmonary receptor modulation of plasma renin activity in normotensive and hypertensive subjects 374
Need for information and locus of control among hypertensive patients 363
Early 24-hour blood pressure elevation in normotensive subjects with parental hypertension 351
Comparison of cardiovascular, renal, and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects 346
Effect on resting blood pressure and blood pressure homeostasis of short-term administration of the alpha 1-adrenergic receptor antagonist, trimazosin, in hypertension 345
Effects of different sodium intakes on the antihypertensive and renal effects of single oral doses of nifedipine in hypertensive patients 336
Cardiopulmonary reflex before and after regression of left ventricular hypertrophy in essential hypertension 333
Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: Data from the Pressioni Arteriose Monitorate e Loro Associazioni study 331
Effects of antihypertensive drugs on carotid intima-media thickness: Focus on angiotensin II receptor blockers. A review of randomized, controlled trials 330
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 329
Cardiopulmonary receptor regulation of renin release 325
The development of new antihypertensive drugs with specific properties for the treatment of established hypertension 322
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 322
Antihypertensive and water and sodium balance effects of felodipine, a new vasodilating calcium antagonist, in hypertensive patients 313
Habitual coffee consumption and risk of cardiovascular and all-cause mortality in the PAMELA hypertensive population 312
Left atrial volume in elite athletes: A meta-analysis of echocardiographic studies 308
Mineralocorticoid hypertension due to a nasal spray containing 9 alpha-fluoroprednisolone 307
Neurogenic abnormalities in masked hypertension 305
Prevalence and severity of echocardiographic left ventricular hypertrophy in hypertensive patients in clinical practice 305
Effects of single and repeated doses of the calcium antagonist felodipine on blood pressure, renal function, electrolytes and water balance, and renin-angiotensin-aldosterone system in hypertensive patients 301
Self-Reported Weight and Height: Implications for Left Ventricular Hypertrophy Detection. An Italian Multi-Center Study 300
Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study 298
Effects of moderate low sodium/high potassium diet on essential hypertension: results of a comparative study 294
Structural alterations of the retinal microcirculation in the "prehypertensive" high-normal blood pressure state 292
Prognostic Significance of Left Atrial Enlargement in a General Population: Results of the PAMELA Study 292
Effects of ageing on the cardiopulmonary receptor reflex in normotensive humans 288
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension 287
Left ventricular geometry and diastolic function in the hypertensive heart: Impact of age 283
Renal and antihypertensive effects of felodipine in hypertensive patients 282
Prevalence and Correlates of Echocardiographic Left Atrial Enlargement in Hypertensive Outpatients in Clinical Practice 281
Adding Home and/or Ambulatory Blood Pressure to Office Blood Pressure for Cardiovascular Risk Prediction 281
Impact of demographic, anthropometric, haemodynamic factors on left atrial size in the general population: data from the PAMELA study 280
Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method 279
Extreme dipping: Always means nocturnal hypotension? 278
Normal values of left-ventricular mass: echocardiographic findings from the PAMELA study 274
Relationships between residual blood pressure variability and cognitive function in the general population of the PAMELA study 274
New-onset left atrial enlargement in a general population 272
[Pseudo-Conn's syndrome after habitual ingestion of liquorice. Report on various clinical cases] 271
The association between 24-h blood pressure patterns and left ventricular mechanics 271
High normal blood pressure and left ventricular hypertrophy echocardiographic findings from the PAMELA population 269
Treatment of hypertension: The ESH/ESC guidelines recommendations 268
Echocardiography in clinical practice: The burden of arterial hypertension. A multicenter Italian survey 264
Hemodynamic, humoral and renal effects of the acute administration of nifedipine in hypertensive patients 264
The impact of arterial hypertension on left ventricular strain in patients with aortic stenosis and preserved ejection fraction. 264
Association of left atrial enlargement with left ventricular hypertrophy and diastolic dysfunction: A tissue Doppler study in echocardiographic practice 263
Metabolic syndrome, left ventricular hypertrophy and carotid atherosclerosis in hypertension: A gender-based study 263
How reliable is isolated clinical hypertension defined by a single 24-h ambulatory blood pressure monitoring? 260
Effects of long-term lercanidipine or hydrochlorothiazide administration on hypertension-related vascular structural changes 260
Metabolic syndrome and multiple organ damage in essential hypertension 259
Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients 259
Ambulatory heart rate and target organ damage in never-treated essential hypertensives 257
Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents? 257
Aortic root dilatation in hypertensive patients: A multicenter survey in echocardiographic practice 255
Blood pressure control in hypertension. Pros and cons of available treatment strategies 254
Nocturnal blood pressure in untreated essential hypertensives 253
Risk of mortality in relation to an updated classification of left ventricular geometric abnormalities in a general population: The PAMELA Study 252
Comprendere l'ipertensione; percezioni della malattia e bisogno informativo in un campione di pazienti ipertesi 252
Studies on left ventricular hypertrophy regression in arterial hypertension: a clear message for the clinician? 251
Carotid atherosclerosis and cardiovascular risk stratification: role and cost-effectiveness of echo-Doppler examination in untreated essential hypertensives 251
Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness 251
Evaluating a tailored message intervention for improving hypertension outcomes 251
Correlation between arterial pressure at rest and during effort and left ventricular mass in hypertensive patients who were never treated 251
Is blunted heart rate decrease at night associated with prevalent organ damage in essential hypertension? 250
Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality 247
Is night-time hypertension worse than daytime hypertension? A study on cardiac damage in a general population: The PAMELA study 246
SYMPATHETIC OVERDRIVE IN THE RESISTANT HYPERTENSIVE PHENOTYPE 246
Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: Results from the Assessment Prognostic Risk Observational Survey (APROS) 245
Effects of bariatric surgery on cardiac structure and function: a systematic review and meta-analysis 245
Clinical evaluation of a new antihypertensive drug (Indapamide) 245
Elevated Blood Pressure And Cardiac Mechanics In Children And Adolescents: A Systematic Review And Meta-Analysis 244
Limited reproducibility of MUCH and WUCH: Evidence from the ELSA study 244
Echocardiographic aortic root dilatation in hypertensive patients: a systematic review and meta-analysis 243
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 242
Obesity and heart failure with preserved ejection fraction: a paradox or something else? 242
Differential value of left ventricular mass index and wall thickness in predicting cardiovascular prognosis: Data from the PAMELA population 241
Incident Left Ventricular Hypertrophy in Masked Hypertension 241
Left atrial function in elite athletes: A meta-analysis of two-dimensional speckle tracking echocardiographic studies 240
Indexation of left ventricular mass to body surface area and height to allometric power of 2.7: Is the difference limited to obese hypertensives? 238
Mitral deceleration index is associated with aortic root dilatation and not to biventricular structural changes in essential hypertension 238
Is retinal arteriolar-venular associated with cardiac and extracardiac organ damage in essential hypertension? 237
How does subclinical hyperthyroidism affect right heart function and mechanics? 237
Left ventricular hypertrophy and abdominal aorta size in essential hypertension 234
Left ventricular diastolic dysfunction in elderly hypertensives: results of the APROS-diadys study 232
Metabolic syndrome and target organ damage: Role of blood pressure 232
Blood Pressure Responses to Renal Denervation Precede and Are Independent of the Sympathetic and Baroreflex Effects 232
How does blood pressure change in hypertensive patients with atrial fibrillation after successful electrical cardioversion? 232
Masked hypertension: an independent predictor of organ damage 229
New onset left atrial dilatation in the general population: A quarter-century follow-up 228
Left and right atrial phasic function and deformation in untreated patients with prediabetes and type 2 diabetes mellitus. 228
Evaluating a tailored message intervention for improving hypertension outcomes 228
Uric Acid and New Onset Left Ventricular Hypertrophy: Findings From the PAMELA Population 228
Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: Findings from the BP-CARE study 227
Prevalence and correlates of multiple organ damage in referred treated hypertensives: Data from the ETODH study 226
Comparison of electrocardiographic versus echocardiographic detection of left ventricular mass changes over time and evaluation of new onset left ventricular hypertrophy 225
Prevalence and correlates of multiple organ damage in a never-treated hypertensive population: role of ambulatory blood pressure 225
Totale 27.947
Categoria #
all - tutte 349.759
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 349.759


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.275 473 536 888 444 393 369 359 406 416 382 515 1.094
2022/20236.284 1.085 1.785 392 401 366 1.082 83 307 403 69 213 98
2023/20245.325 143 112 112 187 918 1.380 964 84 741 105 57 522
2024/202514.957 922 1.946 411 671 1.382 386 520 484 2.090 1.930 1.358 2.857
2025/202637.091 3.561 2.468 2.740 3.195 3.564 1.899 4.605 1.756 2.701 2.686 4.272 3.644
2026/2027558 558 0 0 0 0 0 0 0 0 0 0 0
Totale 104.927